<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVES: To evaluate 1) how many patients with <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> (AF) and <z:hpo ids='HP_0001635'>heart failure</z:hpo> were discharged from Austrian hospitals with antithrombotic therapy, 2) if the presence of risk factors for <z:hpo ids='HP_0001297'>stroke</z:hpo>/embolism (age &gt; 65 years, arterial <z:hpo ids='HP_0000822'>hypertension</z:hpo>, <z:mp ids='MP_0002055'>diabetes</z:mp>, and previous <z:hpo ids='HP_0001297'>stroke</z:hpo>) influence the choice of antithrombotic therapy and if the presence of contraindications for oral anticoagulation (<z:hpo ids='HP_0000726'>dementia</z:hpo>, <z:e sem="disease" ids="C0085762" disease_type="Mental or Behavioral Dysfunction" abbrv="aca">alcohol abuse</z:e>) influence the choice of antithrombotic therapy, and 3) if there are differences among the types of departments in the use of antithrombotic therapy </plain></SENT>
<SENT sid="1" pm="."><plain>PATIENTS: Included were 1566 patients (841 female, 725 male, mean age 76 years) with AF and <z:hpo ids='HP_0001635'>heart failure</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: At discharge, a questionnaire was completed including risk factors, contraindications for antithrombotic therapy, and antithrombotic medication </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: Oral <z:chebi fb="2" ids="50249">anticoagulants</z:chebi> (OAC) had 26% of the cases, <z:chebi fb="9" ids="46887">acetyl</z:chebi> <z:chebi fb="4" ids="16914">salicylic acid</z:chebi> (<z:chebi fb="37" ids="15365">ASA</z:chebi>) 31%, a combination of OAC and <z:chebi fb="37" ids="15365">ASA</z:chebi> 2%, and no antithrombotic therapy 41% </plain></SENT>
<SENT sid="4" pm="."><plain>The risk factors age &gt; 65 years, arterial <z:hpo ids='HP_0000822'>hypertension</z:hpo>, <z:mp ids='MP_0002055'>diabetes</z:mp>, and previous <z:hpo ids='HP_0001297'>stroke</z:hpo> did not influence the choice of antithrombotic therapy </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0000726'>Dementia</z:hpo> but not <z:e sem="disease" ids="C0085762" disease_type="Mental or Behavioral Dysfunction" abbrv="aca">alcohol abuse</z:e> influenced the choice against OAC </plain></SENT>
<SENT sid="6" pm="."><plain>The rate of OAC was higher in cardiological or cardiovascular rehabilitation clinics than in other departments </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSION: The results of this survey show that in medical practice the recommendations regarding antithrombotic therapy in <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> are rarely considered, especially when additional risk factors are present </plain></SENT>
</text></document>